| Catalog | Description | Size | Price (USD) | Qty |
|---|---|---|---|---|
| GBM-2300-10MG | Paliperidone | 10mg | $63.00 | |
| GBM-2300-50MG | Paliperidone | 50mg | $231.00 |
| Bioassays Specification | |
| Bio-Activity | Risperidone metabolite |
| Chemical Name | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
| Function / Pharmacology | Pharmacologically active metabolite of risperidone, an atypical antipsychotic agent.1 Displays high affinity for serotonin 5-HT2A receptors as well as dopamine D2 receptors.2,3 |
| CAS# | 144598-75-4 |
| MW | 426.48 |
| Molecular Formula | C23H27FN4O3 |
| Solubility | Soluble in DMSO (up to 4 mg/ml) |
| Supplied | powder |
| Storage as supplied | RT |
| Ship temp | Ambient |
| References | 1) Beijsterveldt et al. (1994), Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat; Psychopharmacology, 114 53 2) Leysen et al. (1994), Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity; J. Clin. Psychiatry, 55 suppl: 5 3) Schotte et al. (1996), Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding; Psychopharmacology (Berl.), 124 57 |
| Antibody Specification | |
| Alternate Names | Paliperidone; 9-hydroxyrisperidone |
| Protein Specification | |
| Purity | >98% |
| Bioassays Specification | |
| Bio-Activity | Risperidone metabolite |
| Chemical Name | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
| Function / Pharmacology | Pharmacologically active metabolite of risperidone, an atypical antipsychotic agent.1 Displays high affinity for serotonin 5-HT2A receptors as well as dopamine D2 receptors.2,3 |
| CAS# | 144598-75-4 |
| MW | 426.48 |
| Molecular Formula | C23H27FN4O3 |
| Solubility | Soluble in DMSO (up to 4 mg/ml) |
| Supplied | powder |
| Storage as supplied | RT |
| Ship temp | Ambient |
| References | 1) Beijsterveldt et al. (1994), Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat; Psychopharmacology, 114 53 2) Leysen et al. (1994), Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity; J. Clin. Psychiatry, 55 suppl: 5 3) Schotte et al. (1996), Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding; Psychopharmacology (Berl.), 124 57 |
| Antibody Specification | |
| Alternate Names | Paliperidone; 9-hydroxyrisperidone |
| Protein Specification | |
| Purity | >98% |
